FBTCX Fidelity Advisor Biotechnology C Forecast, Technical & Fundamental Analysis

The most notable companies in this group are ABBVIE (NYSE:ABBV), Amgen (NASDAQ:AMGN), Gilead Sciences (NASDAQ:GILD), Regeneron Pharmaceuticals (NASDAQ:REGN).

The investment seeks capital appreciation. The fund invests primarily in common stocks. It normally invests at least 80% of assets in securities of companies principally engaged in the research, development, manufacture, and distribution of various biotechnological products, services, and processes, and companies that benefit significantly from scientific and technological advances in biotechnology. The fund invests in domestic and foreign issuers. It uses fundamental analysis of factors such as each issuer's financial condition and industry position, as well as market and economic conditions, to select investments. The fund is non-diversified.

The average market capitalization across the Fidelity Advisor Biotechnology C MF is 94.21B. The market cap for tickers in the group ranges from 4.04B to 414.77B. ABBV holds the highest valuation in this group at 414.77B. The lowest valued company is VKTX at 4.04B.

The average weekly volume growth across all stocks in the Fidelity Advisor Biotechnology C MF was 35%. For the same stocks of the MF, the average monthly volume growth was 66% and the average quarterly volume growth was 261%